c-fos antisense oligodeoxynucleotide reduces VIP-induced upregulation of VEGF expression in small cell lung cancer cells

Chinese Journal of Lung Cancer

Volumn 9, Issue 4, 2006, Pages 312-315

  Zhao, Zhengyuan ^a   Cheng, Qingshu ^a   Li, Xiaofei ^a   Wang, Xiaoping ^a   Liu, Kun ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Angiogenesis; Antisense oligodeoxynucleotide; c fos; Small cell lung cancer; Vascular endothelial growth factor; Vasoactive intestinal peptide

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; MESSENGER RNA; PROTEIN C FOS; VASCULOTROPIN;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; LUNG SMALL CELL CANCER; PROTEIN EXPRESSION; UPREGULATION;

EID: 33748108163     PISSN: 10093419     EISSN: 19996187     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Moody TW, Hill JM, Jensen RT. VIP as a trophic factor in the CNS and cancer cells. Peptides, 2003, 24(1): 163-177.
2. Zia H, Hida T, Jakowlew S, et al. Breast cancer growth is inhibited by vasoactive intestinal peptide (VIP) hybrid, a synthetic VIP receptor antagonist. Cancer Res, 1996, 56(15): 3486-3489.
3. Stefanou D, Goussia AC, Arkoumani E, et al. Expression of vascular endothelial growth factor and the adhesion molecule E-cadherin in non-small cell lung cancer. Anticancer Res, 2003, 23(6C): 4715-4720.
4. Shepherd FA, Sridhar SS. Angiogenesis inhibitors under study for the treatment of lung cancer. Lung Cancer, 2003, 41 (Suppl 1): S63-S72.
5. Maruno K, Said SI. Small-cell lung carcinoma: inhibition of proliferation by vasoactive intestinal peptide and helodermin and enhancement of inhibition by anti-bombesin antibody. Life Sci, 1993, 52 (24): PL267-271.
6. Moody TW, Chan D, Fahrenkrug J, et al. Neuropeptides as autocrine growth factors in cancer cells. Curr Pharm Des, 2003, 9(6): 495-509.
7. Moody TW, Zia F, Draoui M, et al. A vasoactive intestinal peptide antagonist inhibits non-small cell lung cancer growth. Proc Natl Acad Sci U S A, 1993, 90(10): 4345-4349.
8. Ben-Av P, Crofford LJ, Wilder RL, et al. Induction of vascular endothelial growth factor expression in synovial fibroblasts by prostaglandin E and interleukin-1: a potential mechanism for inflammatory angiogenesis. FEBS Lett, 1995, 372(1): 83-87.
9. Moody TW, Walters J, Casibang M, et al. VPAC1 receptors and lung cancer. Ann N Y Acad Sci, 2000, 921(1): 26-32.